questionsmedicales.fr
Régions géographiques
Océanie
Australasie
Australasie : Questions médicales fréquentes
Termes MeSH sélectionnés :
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Australasie : Questions médicales les plus fréquentes",
"headline": "Australasie : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Australasie : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-04-22",
"dateModified": "2025-04-17",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Australasie"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Océanie",
"url": "https://questionsmedicales.fr/mesh/D044349",
"about": {
"@type": "MedicalCondition",
"name": "Océanie",
"code": {
"@type": "MedicalCode",
"code": "D044349",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "Z01.678"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Australie",
"alternateName": "Australia",
"url": "https://questionsmedicales.fr/mesh/D001315",
"about": {
"@type": "MedicalCondition",
"name": "Australie",
"code": {
"@type": "MedicalCode",
"code": "D001315",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "Z01.678.100.373"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Territoire de la capitale australienne",
"alternateName": "Australian Capital Territory",
"url": "https://questionsmedicales.fr/mesh/D020958",
"about": {
"@type": "MedicalCondition",
"name": "Territoire de la capitale australienne",
"code": {
"@type": "MedicalCode",
"code": "D020958",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "Z01.678.100.373.500"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Nouvelle-Galles du Sud",
"alternateName": "New South Wales",
"url": "https://questionsmedicales.fr/mesh/D009517",
"about": {
"@type": "MedicalCondition",
"name": "Nouvelle-Galles du Sud",
"code": {
"@type": "MedicalCode",
"code": "D009517",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "Z01.678.100.373.750"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Territoire du Nord",
"alternateName": "Northern Territory",
"url": "https://questionsmedicales.fr/mesh/D015876",
"about": {
"@type": "MedicalCondition",
"name": "Territoire du Nord",
"code": {
"@type": "MedicalCode",
"code": "D015876",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "Z01.678.100.373.875"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Queensland",
"alternateName": "Queensland",
"url": "https://questionsmedicales.fr/mesh/D011793",
"about": {
"@type": "MedicalCondition",
"name": "Queensland",
"code": {
"@type": "MedicalCode",
"code": "D011793",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "Z01.678.100.373.937"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Australie-Méridionale",
"alternateName": "South Australia",
"url": "https://questionsmedicales.fr/mesh/D013021",
"about": {
"@type": "MedicalCondition",
"name": "Australie-Méridionale",
"code": {
"@type": "MedicalCode",
"code": "D013021",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "Z01.678.100.373.968"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Tasmanie",
"alternateName": "Tasmania",
"url": "https://questionsmedicales.fr/mesh/D013648",
"about": {
"@type": "MedicalCondition",
"name": "Tasmanie",
"code": {
"@type": "MedicalCode",
"code": "D013648",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "Z01.678.100.373.984"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Victoria",
"alternateName": "Victoria",
"url": "https://questionsmedicales.fr/mesh/D014739",
"about": {
"@type": "MedicalCondition",
"name": "Victoria",
"code": {
"@type": "MedicalCode",
"code": "D014739",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "Z01.678.100.373.992"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Australie occidentale",
"alternateName": "Western Australia",
"url": "https://questionsmedicales.fr/mesh/D014904",
"about": {
"@type": "MedicalCondition",
"name": "Australie occidentale",
"code": {
"@type": "MedicalCode",
"code": "D014904",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "Z01.678.100.373.996"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Nouvelle-Zélande",
"alternateName": "New Zealand",
"url": "https://questionsmedicales.fr/mesh/D009520",
"about": {
"@type": "MedicalCondition",
"name": "Nouvelle-Zélande",
"code": {
"@type": "MedicalCode",
"code": "D009520",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "Z01.678.100.747"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Iles du Pacifique",
"alternateName": "Pacific Islands",
"url": "https://questionsmedicales.fr/mesh/D010139",
"about": {
"@type": "MedicalCondition",
"name": "Iles du Pacifique",
"code": {
"@type": "MedicalCode",
"code": "D010139",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "Z01.678.100.873"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Australasie",
"alternateName": "Australasia",
"code": {
"@type": "MedicalCode",
"code": "D044362",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "None None",
"url": "https://questionsmedicales.fr/author/None%20None",
"affiliation": {
"@type": "Organization",
"name": ""
}
},
{
"@type": "Person",
"name": "Ainsley J Newson",
"url": "https://questionsmedicales.fr/author/Ainsley%20J%20Newson",
"affiliation": {
"@type": "Organization",
"name": "Faculty of Medicine and Health, Sydney School of Public Health, Sydney Health Ethics, The University of Sydney, Sydney, NSW, Australia."
}
},
{
"@type": "Person",
"name": "Thomas Beaney",
"url": "https://questionsmedicales.fr/author/Thomas%20Beaney",
"affiliation": {
"@type": "Organization",
"name": "Imperial Clinical Trials Unit, Imperial College London, Stadium House, 68 Wood Lane, London, UK."
}
},
{
"@type": "Person",
"name": "Xin Xia",
"url": "https://questionsmedicales.fr/author/Xin%20Xia",
"affiliation": {
"@type": "Organization",
"name": "Imperial Clinical Trials Unit, Imperial College London, Stadium House, 68 Wood Lane, London, UK."
}
},
{
"@type": "Person",
"name": "Neil R Poulter",
"url": "https://questionsmedicales.fr/author/Neil%20R%20Poulter",
"affiliation": {
"@type": "Organization",
"name": "Imperial Clinical Trials Unit, Imperial College London, Stadium House, 68 Wood Lane, London, UK."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Tablet characteristics and pharmacokinetics of orally disintegrating tablets containing coenzyme Q10 granules prepared by different methods.",
"datePublished": "2023-01-24",
"url": "https://questionsmedicales.fr/article/36692467",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.2478/acph-2023-0007"
}
},
{
"@type": "ScholarlyArticle",
"name": "Impact of Raman mapping area and intra-tablet homogeneity on the accuracy of sustained-release tablet dissolution prediction.",
"datePublished": "2023-07-22",
"url": "https://questionsmedicales.fr/article/37488047",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.ejpb.2023.07.012"
}
},
{
"@type": "ScholarlyArticle",
"name": "Controlling the lag-time and release kinetics of press-coated tablets using process parameters and tablet geometry.",
"datePublished": "2022-09-29",
"url": "https://questionsmedicales.fr/article/36183918",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.ijpharm.2022.122252"
}
},
{
"@type": "ScholarlyArticle",
"name": "Indices for the brittleness of pharmaceutical tablets: A reassessment.",
"datePublished": "2023-09-03",
"url": "https://questionsmedicales.fr/article/37661031",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.ijpharm.2023.123364"
}
},
{
"@type": "ScholarlyArticle",
"name": "Influence of compression kinetics during tableting of fluidized bed-granulated microorganisms on microbiological and physical-mechanical tablet properties.",
"datePublished": "2023-05-18",
"url": "https://questionsmedicales.fr/article/37207944",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.ejpb.2023.05.012"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Régions géographiques",
"item": "https://questionsmedicales.fr/mesh/D005842"
},
{
"@type": "ListItem",
"position": 3,
"name": "Océanie",
"item": "https://questionsmedicales.fr/mesh/D044349"
},
{
"@type": "ListItem",
"position": 4,
"name": "Australasie",
"item": "https://questionsmedicales.fr/mesh/D044362"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Australasie - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Australasie",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-17",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Australasie",
"description": "Comment diagnostiquer une maladie tropicale en Australasie ?\nQuels tests sont utilisés pour le paludisme en Australasie ?\nComment identifier une infection par le virus Zika ?\nQuels sont les signes d'une infection à leptospirose ?\nComment diagnostiquer une maladie de Lyme en Australasie ?",
"url": "https://questionsmedicales.fr/mesh/D044362?mesh_terms=Tablets&page=2#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Australasie",
"description": "Quels sont les symptômes du chikungunya ?\nComment se manifeste la dengue ?\nQuels signes indiquent une infection par le virus de l'herpès ?\nQuels symptômes d'une intoxication alimentaire ?\nComment reconnaître une infection respiratoire ?",
"url": "https://questionsmedicales.fr/mesh/D044362?mesh_terms=Tablets&page=2#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Australasie",
"description": "Comment prévenir la dengue en Australasie ?\nQuelles mesures pour éviter le chikungunya ?\nComment se protéger contre le virus Zika ?\nQuelles sont les recommandations pour la leptospirose ?\nComment prévenir les infections respiratoires ?",
"url": "https://questionsmedicales.fr/mesh/D044362?mesh_terms=Tablets&page=2#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Australasie",
"description": "Quels traitements pour la dengue ?\nComment traiter une infection par le virus Zika ?\nQuels médicaments pour le chikungunya ?\nComment traiter une infection à leptospirose ?\nQuels sont les traitements pour la maladie de Lyme ?",
"url": "https://questionsmedicales.fr/mesh/D044362?mesh_terms=Tablets&page=2#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Australasie",
"description": "Quelles complications peuvent survenir avec la dengue ?\nQuels risques associés au chikungunya ?\nQuelles complications de l'infection par le virus Zika ?\nQuelles complications de la leptospirose ?\nQuels risques de la maladie de Lyme non traitée ?",
"url": "https://questionsmedicales.fr/mesh/D044362?mesh_terms=Tablets&page=2#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Australasie",
"description": "Quels sont les facteurs de risque pour la dengue ?\nQui est à risque pour le chikungunya ?\nQuels facteurs augmentent le risque de virus Zika ?\nQuels sont les risques associés à la leptospirose ?\nQui est à risque pour la maladie de Lyme ?",
"url": "https://questionsmedicales.fr/mesh/D044362?mesh_terms=Tablets&page=2#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une maladie tropicale en Australasie ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un diagnostic repose sur l'historique médical, les symptômes et des tests de laboratoire."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour le paludisme en Australasie ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests de diagnostic incluent les frottis sanguins et les tests de dépistage rapide."
}
},
{
"@type": "Question",
"name": "Comment identifier une infection par le virus Zika ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'infection est confirmée par des tests sanguins spécifiques et l'historique de voyage."
}
},
{
"@type": "Question",
"name": "Quels sont les signes d'une infection à leptospirose ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent fièvre, douleurs musculaires et éruption cutanée, nécessitant des tests."
}
},
{
"@type": "Question",
"name": "Comment diagnostiquer une maladie de Lyme en Australasie ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur l'exposition aux tiques et des tests sérologiques spécifiques."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes du chikungunya ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent fièvre, douleurs articulaires et éruptions cutanées."
}
},
{
"@type": "Question",
"name": "Comment se manifeste la dengue ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "La dengue se manifeste par une forte fièvre, des douleurs corporelles et des éruptions cutanées."
}
},
{
"@type": "Question",
"name": "Quels signes indiquent une infection par le virus de l'herpès ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les signes incluent des lésions cutanées, des démangeaisons et des douleurs localisées."
}
},
{
"@type": "Question",
"name": "Quels symptômes d'une intoxication alimentaire ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent nausées, vomissements, diarrhée et douleurs abdominales."
}
},
{
"@type": "Question",
"name": "Comment reconnaître une infection respiratoire ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent toux, fièvre, essoufflement et douleurs thoraciques."
}
},
{
"@type": "Question",
"name": "Comment prévenir la dengue en Australasie ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Éliminer les eaux stagnantes et utiliser des répulsifs contre les moustiques."
}
},
{
"@type": "Question",
"name": "Quelles mesures pour éviter le chikungunya ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Utiliser des moustiquaires et des répulsifs, et éviter les zones infestées."
}
},
{
"@type": "Question",
"name": "Comment se protéger contre le virus Zika ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Éviter les piqûres de moustiques et utiliser des préservatifs lors de rapports sexuels."
}
},
{
"@type": "Question",
"name": "Quelles sont les recommandations pour la leptospirose ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Éviter le contact avec des eaux potentiellement contaminées et porter des vêtements de protection."
}
},
{
"@type": "Question",
"name": "Comment prévenir les infections respiratoires ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Se laver les mains régulièrement et éviter les contacts avec des personnes malades."
}
},
{
"@type": "Question",
"name": "Quels traitements pour la dengue ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement est symptomatique, avec des analgésiques et une hydratation adéquate."
}
},
{
"@type": "Question",
"name": "Comment traiter une infection par le virus Zika ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il n'existe pas de traitement spécifique ; le repos et l'hydratation sont recommandés."
}
},
{
"@type": "Question",
"name": "Quels médicaments pour le chikungunya ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les anti-inflammatoires et les analgésiques sont utilisés pour soulager les symptômes."
}
},
{
"@type": "Question",
"name": "Comment traiter une infection à leptospirose ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement comprend des antibiotiques et un suivi médical pour éviter les complications."
}
},
{
"@type": "Question",
"name": "Quels sont les traitements pour la maladie de Lyme ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les antibiotiques sont le traitement principal, surtout s'ils sont administrés tôt."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec la dengue ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent la dengue sévère, pouvant entraîner des hémorragies et un choc."
}
},
{
"@type": "Question",
"name": "Quels risques associés au chikungunya ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des douleurs articulaires chroniques peuvent persister longtemps après l'infection."
}
},
{
"@type": "Question",
"name": "Quelles complications de l'infection par le virus Zika ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le virus peut causer des malformations congénitales si contracté pendant la grossesse."
}
},
{
"@type": "Question",
"name": "Quelles complications de la leptospirose ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent des lésions rénales, hépatiques et des hémorragies pulmonaires."
}
},
{
"@type": "Question",
"name": "Quels risques de la maladie de Lyme non traitée ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications peuvent inclure des problèmes neurologiques et des douleurs articulaires chroniques."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque pour la dengue ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent vivre dans des zones tropicales et avoir des antécédents d'infection."
}
},
{
"@type": "Question",
"name": "Qui est à risque pour le chikungunya ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les personnes âgées et celles avec des maladies chroniques sont plus vulnérables."
}
},
{
"@type": "Question",
"name": "Quels facteurs augmentent le risque de virus Zika ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Voyager dans des zones endommagées par le virus et être enceinte augmentent le risque."
}
},
{
"@type": "Question",
"name": "Quels sont les risques associés à la leptospirose ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les personnes travaillant en milieu rural ou en contact avec des eaux contaminées sont à risque."
}
},
{
"@type": "Question",
"name": "Qui est à risque pour la maladie de Lyme ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les personnes vivant dans des zones boisées ou ayant des activités de plein air sont à risque."
}
}
]
}
]
}
This study aimed to elucidate the characteristics and pharmacokinetics of orally disintegrating tablets (ODTs) containing coenzyme Q10 (CoQ10) granules prepared by spray drying, hot-melting, and wet g...
This exploratory study investigated the minimum required Raman mapping area for predicting sustained-release tablet dissolution profiles based on intra-tablet homogeneity. The aim was to minimize scan...
Press-coated tablets are an advantageous technology to achieve delayed releases of active ingredients. They are characterized by a core-shell structure, that makes it possible to tune the lag-time and...
Brittleness is an important mechanical property. In the classical sense, a material is considered brittle if, during loading, it behaves elastically until failure. Nevertheless, it is also sometimes u...
As tablets are convenient to administer to patients, ensure safe dosing and allow cost-effective production on a large scale, they are the favored dosage form for numerous active pharmaceutical ingred...
For the first time 15 years ago, tablet allergen immunotherapy (T-AIT) formulations were approved by regulatory agencies for treating allergic rhinitis caused by grass pollen in adults and children ag...
Here, we optimize the process used to formulate and prepare dispersible Taohong Siwu tablets and provide a foundation for expanding their clinical application. Taking dispersion uniformity and disinte...
The present study aimed to evaluate Cassia fistula seed galactomannan (CFSG) as a tablet-binder in the formulation of a monolithic matrix tablet using diclofenac sodium as a model drug. Initially, CFS...
Venetoclax is an approved BCL-2 inhibitor, currently under evaluation in different hematological malignancies in adult and pediatric populations. Venetoclax is available as 10, 50, and 100 mg tablets....
Pharmacokinetic data from 80 healthy female participants from three phase I studies were utilized to evaluate the bioavailability of (1) 10 and 50 mg tablets relative to a 100 mg tablet; (2) 0.72 and ...
Bioavailability assessments at a 100 mg dose of venetoclax demonstrated bioequivalence across the 10, 50, and 100 mg tablet strengths. Oral powder formulations met the bioequivalence criteria (0.80-1....
The smaller-sized tablets (10 and 50 mg) and the newly developed oral powder formulations of venetoclax can be used interchangeably with the 100 mg tablets to improve the patients' experience, while m...
This randomized controlled trial compared the efficacy and tolerability of danzhixiaoyao pills in the accurate treatment of patients with burning mouth syndrome (BMS)....
Collect a total of 78 patients (75 female patients and 3 male patients) from the oral mucosa department who were considered eligible fromOctober 2020 to October 2022.The patients were randomized and d...
1.After treatment, the VAS, BDI,OHIP-14, and TCM syndrome integral in the trial group had a significant decrease than the control group(P< 0.05).However, there was no statistical difference in the BAI...
Danzhixiaoyao pills has demonstrated to have a positive effect in relieving BMS symptoms and in improving a patient's overall quality of life with no AEs compared with the control group. The efficacy ...
Registry name: Chinese Clinical trail Registry Registration number: ChiCTR2000038189 Date of Registration: 2020-09-13 Please visit ( https://www.chictr.org.cn/showproj.html?proj=61462 ) to the protoco...